Tempest Therapeutics (TPST) Financials: Revenue & Earnings

TPST price $0.52 +0.01 +1.55%

Ticker
TPST
Price
$0.52
Change
+0.01 +1.55%
Market cap ?
$8.76M
Beta ?
-1.71
Sector
Healthcare
Industry
Biotechnology

Fair value

TPST fair value Not meaningful. Price $0.52.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare TPST

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-0.32——
2026-08-13-0.34-0.30——
2026-05-14-2.53-0.28——
2026-03-31-0.62-0.62——
2025-11-05-0.79-3.27——
2025-08-11-2.07-3.23——
2025-05-13-3.16-3.71——
2025-03-27-4.03-3.12——
2024-11-12-5.33-4.81——
2024-08-08-5.46-6.11——
2024-05-09-4.68-5.72——
2024-03-19-4.42-4.94——
2023-11-08-6.24-7.15——
2023-08-10-7.02-7.54——
2023-05-10-7.15-8.58——
2023-03-22-8.19-0.76——
2022-11-08-0.66-0.80——
2022-08-15-0.79-11.96——
2022-05-13-1.18-1.12——
2022-03-29-1.12-1.23——
2021-11-10-15.73-13.65——
2021-08-12-99.22-11.44——
2021-05-13-6.60-5.25——
2021-03-29-5.85-5.15——
2020-11-09-5.10-6.90——
2020-08-10-8.40-8.20——
2020-05-08-9.75-10.00——
2020-03-11-13.05-12.18——
2019-11-13-13.05-12.38——
2019-08-12-11.10-12.12——
2019-05-15-11.70-10.55——
2019-03-29-12.30-12.853.56M—
2018-11-10-35.70—55.00K—
2018-08-09-48.43—81.00K—
2018-05-03-46.42—67.00K—
2018-03-15-54.00-61.9591.00K103.25K
2017-11-02-58.50-89.7856.00K92.00K
2017-08-03-114.75-94.3384.00K65.78K
2017-05-09-85.50-95.9663.00K60.95K
2017-03-02-110.25-129.94121.00K141.39K

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-22Smith Nancy FredaBuy25.00K$1.0025.00K
2026-09-22Smith Nancy FredaOther0——
2026-06-04Yee John D.Buy25.00K$1.2731.75K
2026-06-04Yee John D.Other0——
2026-06-04Richey William DrakeOther0——
2026-06-04Richey William DrakeBuy25.00K$1.2731.75K
2026-03-31Trojanowski JustinBuy22.00K$1.6436.08K
2026-03-31Maestas NicholasBuy140.00K$1.64229.60K
2026-03-24Angel MatthewBuy231.48K$2.16500.00K
2026-03-24Angel MatthewBuy231.48K$2.16500.00K
2026-03-24Angel MatthewBuy231.48K$2.16500.00K
2026-02-04Angel MatthewBuy269.62K$2.38641.70K
2026-02-03Angel MatthewOther0——
2026-01-27Simantov RonitBuy1.23K$2.943.62K
2026-01-27NICHOL GEOFFREYBuy1.23K$2.943.62K
2026-01-27RAAB MICHAELBuy1.23K$2.943.62K
2026-01-27Pellizzari Christine ABuy1.23K$2.943.62K
2025-01-02Brady Stephen RBuy550.00K$0.86473.00K
2025-01-02Whiting SamuelBuy270.00K$0.86232.20K
2025-01-02Trojanowski JustinBuy30.00K$0.8625.80K
2025-01-02Maestas NicholasBuy200.00K$0.86172.00K
2024-08-12Versant Venture Capital VI, L.P.Sell388.00K$1.10426.99K
2024-08-08Versant Venture Capital VI, L.P.Sell400.00K$1.35540.04K
2024-07-03Brady Stephen RBuy35.00K$2.1173.85K
2024-07-02Whiting SamuelBuy4.67K$2.139.95K
2024-06-28Trojanowski JustinBuy7.50K$2.1616.20K
2024-06-13Pellizzari Christine ABuy16.00K$3.0348.48K
2024-06-13NICHOL GEOFFREYBuy16.00K$3.0348.48K
2024-06-13Simantov RonitBuy16.00K$3.0348.48K
2024-06-13RAAB MICHAELBuy16.00K$3.0348.48K
2024-01-03Brady Stephen RBuy250.00K$4.661.17M
2024-01-03Whiting SamuelBuy100.00K$4.66466.00K
2024-01-03Trojanowski JustinBuy26.50K$4.66123.49K
2024-01-03Maestas NicholasBuy40.00K$4.66186.40K
2023-10-11Brady Stephen RBuy725.00K$9.777.08M
2023-10-11Trojanowski JustinBuy55.00K$9.77537.35K
2023-10-11Whiting SamuelBuy325.00K$9.773.18M
2023-10-11Maestas NicholasBuy100.00K$9.77977.00K
2023-06-15RAAB MICHAELBuy8.20K$1.4211.64K
2023-06-15NICHOL GEOFFREYBuy8.20K$1.4211.64K
2023-06-15Pellizzari Christine ABuy8.20K$1.4211.64K
2023-06-15Simantov RonitBuy8.20K$1.4211.64K
2023-01-03Whiting SamuelBuy69.70K——
2023-01-03Dubensky Thomas W.Buy102.70K——
2023-01-03Brady Stephen RBuy177.30K——
2023-01-03Maestas NicholasBuy38.42K——
2023-01-03Trojanowski JustinBuy20.30K——
2022-10-03Trojanowski JustinBuy2.50K——
2022-09-30Trojanowski JustinSell10.00K$2.2922.90K
2022-06-22Whiting SamuelBuy55.68K——
2022-06-21Lorenzo PierreBuy8.48K——
2022-06-21Maestas NicholasBuy51.27K——
2022-06-21Dubensky Thomas W.Buy87.80K$2.35206.33K
2022-06-21Dubensky Thomas W.Buy87.80K——
2022-06-21Brady Stephen RBuy173.53K——
2022-06-17Pellizzari Christine ABuy3.50K——
2022-06-17NICHOL GEOFFREYBuy3.50K$2.087.28K
2022-06-17NICHOL GEOFFREYBuy3.50K——
2022-06-17Woiwode ThomasBuy3.50K$2.087.28K
2022-06-17Woiwode ThomasBuy3.50K——
2022-06-17Simantov RonitBuy3.50K——
2022-06-17RAAB MICHAELBuy3.50K——
2022-04-29Woiwode ThomasBuy2.12M$2.365.00M
2022-04-29Versant Venture Capital VI, L.P.Other0——
2022-04-29Versant Vantage II, L.P.Sell0——
2022-01-07Dubensky Thomas W.Buy2.00K$4.789.56K
2022-01-06Whiting SamuelBuy1.70K$4.808.17K
2022-01-04Lorenzo PierreBuy6.50K$5.4535.42K
2022-01-04Maestas NicholasBuy19.50K$5.45106.28K
2022-01-04Whiting SamuelBuy29.00K$5.45158.05K
2022-01-04Brady Stephen RBuy94.50K$5.45515.02K
2022-01-04Dubensky Thomas W.Buy53.10K$5.45289.39K
2021-12-30Rock Springs Capital Management LPOther0——
2021-12-30Rock Springs Capital Management LPOther0——
2021-09-21RAAB MICHAELBuy6.63K$15.15100.52K
2021-08-06Simantov RonitBuy6.63K$13.6090.24K
2021-08-06Simantov RonitOther0——
2021-07-12Maestas NicholasBuy23.23K$24.19561.81K
2021-07-12Maestas NicholasOther0——
2021-07-01Pellizzari Christine ABuy6.63K$11.0773.45K
2021-07-01Woiwode ThomasBuy6.63K$11.0773.45K
2021-07-01Xu StellaBuy6.63K$11.0773.45K
2021-07-01NICHOL GEOFFREYBuy6.63K$11.0773.45K
2021-07-01Pellizzari Christine AOther0——
2021-06-25Versant Venture Capital VI, L.P.Other0——
2021-06-25Versant Venture Capital VI, L.P.Sell0——
2021-06-25Versant Venture Capital VI, L.P.Other0——
2021-06-25Whiting SamuelBuy540.23K$26.4014.26M
2021-06-25Whiting SamuelBuy61.95K$5.90365.48K
2021-06-25Whiting SamuelBuy3.02K$10.2530.93K
2021-06-25Whiting SamuelBuy201$1.06213
2021-06-25Whiting SamuelOther0——
2021-06-25Xu StellaBuy579.71K$1.06614.49K
2021-06-25Dubensky Thomas W.Buy1.00M$26.4026.40M
2021-06-25Dubensky Thomas W.Buy111.34K$1.06118.02K
2021-06-25Dubensky Thomas W.Buy45.99K$5.90271.33K
2021-06-25Dubensky Thomas W.Buy36.26K$4.97180.23K
2021-06-25Dubensky Thomas W.Buy8.05K$10.2582.51K
2021-06-25RAAB MICHAELBuy16.78K$4.9783.42K
2021-06-25RAAB MICHAELBuy9.66K$5.9056.99K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 19, holders -1 vs prior quarter. Ownership 6.73%.

HolderSharesChangeChange %Value
SABBY MANAGEMENT, LLC511.29K493.43K+2763.38%567.53K
VANGUARD CAPITAL MANAGEMENT LLC233.89K00.00%259.62K
GEODE CAPITAL MANAGEMENT, LLC86.62K-365-0.42%96.16K
VANGUARD FIDUCIARY TRUST CO68.91K00.00%76.49K
BLACKROCK, INC.39.07K00.00%43.37K
SQUAREPOINT OPS LLC30.90K30.90KNew34.30K
NORTHERN TRUST CORP20.14K6.08K+43.29%22.35K
CITADEL ADVISORS LLC19.82K19.82KNew22.00K
UBS GROUP AG5.64K1.10K+24.33%6.25K
TOWER RESEARCH CAPITAL LLC (TRC)3.92K1.13K+40.57%4.35K
MORGAN STANLEY2.02K-36-1.75%2.24K
OSAIC HOLDINGS, INC.1.51K-16-1.05%1.67K
FEDERATION DES CAISSES DESJARDINS DU QUEBEC29200.00%324
JONES FINANCIAL COMPANIES LLLP23900.00%258
BARCLAYS PLC222222New246
SBI SECURITIES CO., LTD.5600.00%62
PARALLEL ADVISORS, LLC1800.00%20
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD33New3
BNP PARIBAS FINANCIAL MARKETS300.00%3
DIMENSIONAL FUND ADVISORS LP0-11.44K-100.00%0
JPMORGAN CHASE & CO0-5-100.00%0
FMR LLC0-33.23K-100.00%0
CITIGROUP INC0-8-100.00%0
VANGUARD GLOBAL ADVISERS, LLC0-168-100.00%0

Earnings and financials

Tempest Therapeutics, Inc. (TPST) trades at $0.52, with a market cap of $8.76M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Tempest Therapeutics (TPST) Financials: Revenue & Earnings

TPST$0.52+0.01 +1.55%

$8.76M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History